Used primarily in cancer research, particularly for its potential in inhibiting tumor growth and metastasis. It targets Src family kinases, which are involved in signaling pathways that drive cancer cell proliferation, migration, and survival. Shows activity in preclinical models of breast, ovarian, and colorectal cancers. Also investigated for its role in overcoming resistance to other targeted therapies. Has been studied in neurological disorders due to its ability to cross the blood-brain barrier, with potential implications in Alzheimer’s disease by modulating synaptic function. Not approved for clinical use but remains a valuable tool compound in oncology and neuroscience research.